[Form 4] Standex International Corporation Insider Trading Activity

Rhea-AI Filing Summary

Standex International (SXI) Form 4: Annemarie Bell, VP and Chief HR Officer, reported a transaction on 09/03/2025 disposing of 1,184 shares of common stock at $202.12 per share. After the sale she beneficially owns 7,422 shares. The filing indicates the form was signed on 09/04/2025.

Positive

• Clear disclosure of transaction date, price, and post-transaction holdings
• No derivatives or complex transactions reported, simplifying investor assessment

Negative

• Officer sale could be perceived as insider liquidity though size appears modest

Insights

Corporate Governance Expert

TL;DR: Officer sale of a small block of shares; routine disclosure with no automatic governance red flags.

The reported sale of 1,184 shares by a company officer is a routine Section 16 disclosure showing insider liquidity rather than a control change. The remaining beneficial ownership of 7,422 shares is documented. There is no indication of related-party transactions, amendments, or derivative activity in this filing.

Securities Analyst

TL;DR: Transaction is material only as disclosure; size appears modest relative to typical insider holdings.

The Form 4 reports a single open-market sale (code S) at $202.12 per share. With no derivative positions disclosed and a straightforward sale, this is primarily a liquidity event by the reporting officer. The disclosure complies with Section 16 reporting requirements and provides price and post-transaction holdings for investor transparency.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bell Annemarie

(Last) (First) (Middle)

23 KEEWAYDIN DRIVE

SUITE 300

(Street)

SALEM NH 03079

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
STANDEX INTERNATIONAL CORP/DE/ [ SXI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP, Chief HR Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/03/2025		S		1,184	D	$202.12	7,422	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Alan J. Glass	09/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Annemarie Bell report in the Form 4 for SXI?

The filing reports a sale of 1,184 shares of Standex International common stock on 09/03/2025 at $202.12 per share, leaving 7,422 shares beneficially owned.

What is the reporting person's role at Standex (SXI)?

The Form 4 lists the reporting person as an officer with title VP, Chief HR Officer.

Does the Form 4 show any options or derivative holdings for SXI?

No. Table II shows no derivative securities acquired, disposed of, or beneficially owned in this filing.

When was the Form 4 signed and filed?

The signature block shows the form was signed on 09/04/2025.

What transaction code was used in the Form 4 for SXI?

The sale is reported with transaction code S, indicating a sale of existing shares.